DocDollars

Vanda Pharmaceuticals Inc.

DC · United States · Reporting entity ID 100000071361

Total reported 2019–2025
$101.7M
#94 of 2,960 reporting companies — 0.1% of all reported industry payments
$16.5M in general payments across 231,873 records, plus $85.2M in research funding across 6,456 records.

How it breaks down

General payments $16,518,399
Research funding $85,161,868

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Vanda Pharmaceuticals Inc. reported $101.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #94 of 2,960 reporting companies. 84% of that was research funding and 16% general payments such as consulting, speaking, food and travel. 231,873 general payment records and 6,456 research records were filed.

Common questions about Vanda Pharmaceuticals Inc.

How much has Vanda Pharmaceuticals Inc. paid US doctors?

Vanda Pharmaceuticals Inc. reported $101,680,267 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $16,518,399 in general payments, $85,161,868 in research funding.

How does Vanda Pharmaceuticals Inc. rank among drug and device companies?

It ranks #94 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Vanda Pharmaceuticals Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.